Weight Loss Results: 28.3% vs 11.2% What the Phase 3 Data Shows Retatrutide (TRIUMPH trials) TRIUMPH-4 (68 weeks, obesity + osteoarthritis, n=445): 28.7% average weight loss at 12mg dose
Retatrutide acts as a triple agonist on GLP-1, GIP, and glucagon receptors
Preparing for your first shot of Semaglutide is a straightforward process of hydration, mindful eating, and open communication
GLP-1 medications were originally developed to help people with type 2 diabetes, but over time doctors began to notice something remarkable
This is a leading reason why some people stop treatment early
Rather than injecting growth hormone directly, sermorelin stimulates your pituitary gland to produce and release its own human growth hormone (HGH) naturally